Drugs

Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study
Louisa Maria Bulirsch, Marlene Saßmannshausen, Jennifer Nadal, Raffael Liegl, Sarah Thiele, Frank G Holz

British Journal of Ophthalmology Apr 2021, bjophthalmol-2020-318672; DOI: 10.1136/bjophthalmol-2020-318672
Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride
Hong Liang, Antoine Labbé, Christophe Baudouin, Celine Plisson, Vincenzo Giordano

British Journal of Ophthalmology May 2021, 105 (5) 608-613; DOI: 10.1136/bjophthalmol-2020-316450
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic
Rupesh Agrawal, Ilaria Testi, Cecilia S Lee, Edmund Tsui, Marian Blazes, Jennifer E Thorne, Annabelle A Okada, Justine R Smith, Peter J McCluskey, John H Kempen, Christoph Tappeiner, Manisha Agarwal, Bahram Bodaghi, Quan Dong Nguyen, Vishali Gupta, Marc D De Smet, Manfred Zierhut, Carlos Pavesio

British Journal of Ophthalmology May 2021, 105 (5) 639-647; DOI: 10.1136/bjophthalmol-2020-316776
Therapeutic drug monitoring guides the management of patients with chronic non-infectious uveitis treated with adalimumab: a retrospective study
Lucas Sejournet, Sebastien Kerever, Thibaud Mathis, Laurent Kodjikian, Yvan Jamilloux, Pascal Seve

British Journal of Ophthalmology Apr 2021, bjophthalmol-2021-319072; DOI: 10.1136/bjophthalmol-2021-319072
Systemic conbercept pharmacokinetics and VEGF pharmacodynamics following intravitreal injections of conbercept in patients with retinopathy of prematurity
Yong Cheng, Shuang Sun, Xun Deng, Xuemei Zhu, Dandan Linghu, Xiantao Sun, Jianhong Liang

British Journal of Ophthalmology Apr 2021, bjophthalmol-2021-319131; DOI: 10.1136/bjophthalmol-2021-319131
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study
Ha-Lim Jeon, Seong Jun Byun, Nicole L Pratt, Janet Sultana, Sang Jun Park, Ju-Young Shin

British Journal of Ophthalmology Apr 2021, 105 (4) 543-548; DOI: 10.1136/bjophthalmol-2020-316373
Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Wungrak Choi, Hyoung Won Bae, Hye Jung Shin, Eun Woo Kim, Chan Yun Kim, Min Kim, Gong Je Seong

British Journal of Ophthalmology Mar 2021, bjophthalmol-2020-318401; DOI: 10.1136/bjophthalmol-2020-318401
Real-world experience of using ciclosporin-A 0.1% (Ikervis) in the management of ocular surface inflammatory diseases
Rashmi Deshmukh, Darren Shu Jeng Ting, Ahmad Elsahn, Imran Mohammed, Dalia G Said, Harminder Singh Dua

British Journal of Ophthalmology Mar 2021, bjophthalmol-2020-317907; DOI: 10.1136/bjophthalmol-2020-317907
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial
Zhenquan Wu, Jinfeng Zhao, Waiching Lam, Mingmin Yang, Lu Chen, Xuelin Huang, Meirong Wei, Hui Yang, Fan Lv, Fuyan Zhang, Jian Zeng, Guo-Ming Zhang

British Journal of Ophthalmology Feb 2021, bjophthalmol-2020-318026; DOI: 10.1136/bjophthalmol-2020-318026
Medical treatment in thyroid eye disease in 2020
Jwu Jin Khong, Alan McNab

British Journal of Ophthalmology Mar 2021, 105 (3) 299-305; DOI: 10.1136/bjophthalmol-2020-316051

Main menu

Drugs

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Drugs

Pages